source
- Pfizer CFO Dave Denton to leave; Denali Therapeutics sells $195 million FDA priority review voucherPfizer announced that its chief financial officer Dave Denton will depart on Aug. 15 to take a role outside the pharmaceutical sector. He has been CFO since May 2022. In the interim, finance chief…
- Pfizer CFO to leave in August as GSK secures approval for urinary-tract infection drugPfizer announced that its chief financial officer, Dave Denton, will step down in August, ending his tenure at the company. GSK reported that it has received regulatory approval for a new treatmen…